YU31104A - Inhibicija virusa n-dokozanolom - Google Patents
Inhibicija virusa n-dokozanolomInfo
- Publication number
- YU31104A YU31104A YU31104A YUP31104A YU31104A YU 31104 A YU31104 A YU 31104A YU 31104 A YU31104 A YU 31104A YU P31104 A YUP31104 A YU P31104A YU 31104 A YU31104 A YU 31104A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- docosanol
- viral inhibition
- topical
- preparations
- viral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Ovaj pronalazak se odnosi na površinske terapijske preparate i postupke za lečenje virusnih i zapaljenskih oboljenja i redukovanje bola kod površinskih zapaljenja kože i mukoznih membrana. Preparati uključuju kremove koji sadrže n-dokozanol.[This invention relates to topical therapeutic preparations and methods for treating viral and inflammatory diseases and for reducing the pain of topical inflammation of skin and mucous membranes. The preparations include creams containing n-docosanol.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33044401P | 2001-10-16 | 2001-10-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU31104A true YU31104A (sh) | 2006-08-17 |
Family
ID=23289808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU31104A YU31104A (sh) | 2001-10-16 | 2002-10-15 | Inhibicija virusa n-dokozanolom |
Country Status (19)
Country | Link |
---|---|
US (1) | US20040033982A1 (sh) |
EP (1) | EP1436006A4 (sh) |
JP (1) | JP2005519868A (sh) |
CN (1) | CN1633306A (sh) |
AR (1) | AR036834A1 (sh) |
BR (1) | BR0213323A (sh) |
CA (1) | CA2421026C (sh) |
EA (1) | EA200400535A1 (sh) |
HR (1) | HRP20040421B1 (sh) |
HU (1) | HUP0402624A3 (sh) |
IS (1) | IS7212A (sh) |
MX (1) | MXJL04000011A (sh) |
NO (1) | NO20041999L (sh) |
NZ (1) | NZ532944A (sh) |
PL (1) | PL371945A1 (sh) |
RU (1) | RU2004115001A (sh) |
WO (1) | WO2003032915A2 (sh) |
YU (1) | YU31104A (sh) |
ZA (1) | ZA200403707B (sh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7754775B2 (en) * | 2004-04-23 | 2010-07-13 | Mercier Michel F | Multi-lamellar liquid crystal emulsion system |
US9242923B2 (en) | 2010-03-11 | 2016-01-26 | Chemic Laboratories Inc. | Compositons and methods |
US20160089441A1 (en) * | 2014-09-25 | 2016-03-31 | Oralabs, Inc. | Composition for the treatment of cold sores |
CN107961232B (zh) | 2016-10-20 | 2023-05-26 | 维尔信科技(潍坊)有限公司 | 药物调配物和其用途 |
AU2019406674B2 (en) * | 2018-12-19 | 2023-06-15 | Glaxosmithkline Consumer Healthcare Holdings (Us) Llc | Variable dose applicator |
US11951082B2 (en) | 2022-08-22 | 2024-04-09 | Ford Therapeutics, Llc | Composition of chlorhexidine |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1109119A (en) * | 1910-03-29 | 1914-09-01 | Ellis Foster Co | Solidified oil and process of making same. |
US3031376A (en) * | 1956-10-11 | 1962-04-24 | Levin | Compositions comprising octacosanol, triacontanol, tetracosanol, or hexacosanol, andmethods employing same |
US3584115A (en) * | 1968-05-31 | 1971-06-08 | Arthur Ira Gebhart | Method of applying visible aerosol compositions |
US3592930A (en) * | 1968-07-19 | 1971-07-13 | Syntex Corp | Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle |
SE352811B (sh) * | 1971-06-04 | 1973-01-15 | Pharmacia Ab | |
US3946035A (en) * | 1972-06-29 | 1976-03-23 | L'oreal | Anti-inflammatory polymers, pharmaceutical compositions containing the same and process for producing said polymers |
US4076799A (en) * | 1972-12-27 | 1978-02-28 | Cincinnati Milacron, Inc. | Method of inhibiting skin irritation |
GB1459233A (en) * | 1973-08-29 | 1976-12-22 | Inst Rech Chim Biolog | Medicament containing a higher alkanol |
US3987198A (en) * | 1973-10-16 | 1976-10-19 | Syntex (U.S.A.) Inc. | Method for lowering the free fatty acid content in sebum using certain fatty acid amides |
US4199574A (en) * | 1974-09-02 | 1980-04-22 | Burroughs Wellcome Co. | Methods and compositions for treating viral infections and guanine acyclic nucleosides |
GB1523865A (en) * | 1974-09-02 | 1978-09-06 | Wellcome Found | Purine compunds and salts thereof |
US4025645A (en) * | 1976-01-27 | 1977-05-24 | Jelenko Iii Carl | Non-steroid topical agent for alleviating inflammation in mammals |
US4150970A (en) * | 1977-01-03 | 1979-04-24 | Board Of Trustees Of Michigan State University | Growth regulator for plants |
US4200655A (en) * | 1978-08-15 | 1980-04-29 | Sterling Drug Inc. | Benzyl alcohol virucidal process |
US4258029A (en) * | 1979-04-23 | 1981-03-24 | Connaught Laboratories Limited | Synthetic adjuvants for stimulation of antigenic responses |
US4246100A (en) * | 1979-10-22 | 1981-01-20 | Bio-Humus, Inc. | Composition and method for the treatment of sewage |
US4536519A (en) * | 1981-06-15 | 1985-08-20 | Kao Soap Co., Ltd. | Emulsifying agent and emulsified cosmetics |
US4670471A (en) * | 1981-11-03 | 1987-06-02 | Clark Lealand L | Treatment for inflammatory skin disease |
US5658958A (en) * | 1982-05-28 | 1997-08-19 | Eisai Co., Ltd. | β, γ-dihydropolyprenyl alcohol derivatives effective at mitigating stress in animals |
US5280048A (en) * | 1982-05-28 | 1994-01-18 | Eisai Co., Ltd. | β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound |
GB2122610B (en) * | 1982-05-28 | 1987-04-01 | Eisai Co Ltd | A polyprenyl compound and a pharmaceutical composition containing a polyprenyl compound |
AU546872B2 (en) * | 1982-06-16 | 1985-09-26 | Unilever Plc | Skin treatment compositions containing a fatty acid or ester |
US4513008A (en) * | 1982-07-30 | 1985-04-23 | The Vinoxen Company, Inc. | Virucidal compositions and therapy |
EP0158108B1 (en) * | 1984-03-05 | 1992-10-14 | Tonfer Inc. | Detergent composition |
DE3421468A1 (de) * | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
US4623667A (en) * | 1985-06-28 | 1986-11-18 | Richardson-Vicks Inc. | Topical treatment of skin inflammatory disorders |
US4684479A (en) * | 1985-08-14 | 1987-08-04 | Arrigo Joseph S D | Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures |
GB8602346D0 (en) * | 1986-01-30 | 1986-03-05 | Wellcome Found | Antiviral combinations |
US4793991A (en) * | 1986-01-31 | 1988-12-27 | Slimak Karen M | Hypoallergenic cosmetics, lip balms and lip sticks |
US5208257A (en) * | 1986-04-21 | 1993-05-04 | Kabara Jon J | Topical antimicrobial pharmaceutical compositions and methods |
US5030448A (en) * | 1986-05-15 | 1991-07-09 | Emory University | Method of delivering drugs to damaged or diseased tissue |
US4879109A (en) * | 1986-05-15 | 1989-11-07 | Emory University | Method for treating burns |
US4900555A (en) * | 1987-02-26 | 1990-02-13 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
US4865848A (en) * | 1987-02-26 | 1989-09-12 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
US4940586A (en) * | 1987-02-26 | 1990-07-10 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
US5380754A (en) * | 1988-02-29 | 1995-01-10 | Virotex Corporation | Topical composition enhancing healing of viral lesions |
US5135956A (en) * | 1988-10-18 | 1992-08-04 | The Regents Of The University Of California | Method of using cytoprotective alcohols to treat neural disease and neural injury |
US5216142A (en) * | 1989-04-17 | 1993-06-01 | Efamol Holdings Plc | Anti-virals |
US5071879A (en) * | 1989-04-28 | 1991-12-10 | Lidak Pharmaceuticals | Systemic antiviral treatment |
US4874794A (en) * | 1989-04-28 | 1989-10-17 | Lidak Biopharmaceuticals | Inflammatory disease treatment |
US5070107A (en) * | 1989-04-28 | 1991-12-03 | Lidak Pharmaceuticals | Systemic antiviral treatment |
US5104656A (en) * | 1989-06-16 | 1992-04-14 | Seth Pyare L | Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent |
US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
US4956171A (en) * | 1989-07-21 | 1990-09-11 | Paco Pharmaceutical Services, Inc. | Transdermal drug delivery using a dual permeation enhancer and method of performing the same |
US5194451A (en) * | 1989-11-02 | 1993-03-16 | Katz David H | Systemic anti-inflammatory treatment |
US5166219A (en) * | 1989-11-02 | 1992-11-24 | Lidak Pharmaceuticals | Systemic anti-inflammatory treatment |
JPH03157349A (ja) * | 1989-11-14 | 1991-07-05 | Lion Corp | 乳化組成物 |
DE4111105A1 (de) * | 1991-04-05 | 1992-10-08 | Max Planck Gesellschaft | Neue erucyl-, brassidyl- und nervonylderivate |
US5250236A (en) * | 1991-08-05 | 1993-10-05 | Gasco Maria R | Method for producing solid lipid microspheres having a narrow size distribution |
US5580571A (en) * | 1991-10-15 | 1996-12-03 | Hostetler; Karl Y. | Nucleoside analogues |
CN1041632C (zh) * | 1993-09-10 | 1999-01-13 | 里科达蒂化学药物公司 | 制备9-(2-羟基)-乙氧甲基鸟嘌呤的方法 |
EP1473031B1 (en) * | 1993-12-13 | 2008-06-25 | AVANIR Pharmaceuticals | Sucrose ester - C20 to C28 alcohol formulations |
KR100396278B1 (ko) * | 1994-03-21 | 2003-11-28 | 톰슨 존 브라운 | 피부질환의치료및피부의살균용겔 |
US5447729A (en) * | 1994-04-07 | 1995-09-05 | Pharmavene, Inc. | Multilamellar drug delivery systems |
US5869529A (en) * | 1994-07-20 | 1999-02-09 | Agis Industries (1983) Ltd. | Topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus |
US5567816A (en) * | 1994-07-26 | 1996-10-22 | Syntex (U.S.A.) Inc. | Preparation of acyclovir using 1,3 dioxolane |
US5667492A (en) * | 1994-10-07 | 1997-09-16 | Columbia Laboratories, Inc. | Use and composition of an anti-sexually transmitted diseases formulation |
US5883103A (en) * | 1995-06-07 | 1999-03-16 | Shire Laboratories Inc. | Oral acyclovir delivery |
EP1001759B1 (en) * | 1996-09-17 | 2005-07-20 | Avanir Pharmaceuticals | Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
US6440980B1 (en) * | 1996-09-17 | 2002-08-27 | Avanir Pharmaceuticals | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
US5952392A (en) * | 1996-09-17 | 1999-09-14 | Avanir Pharmaceuticals | Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition |
US5948822A (en) * | 1996-12-17 | 1999-09-07 | Lidak Pharmaceuticals | Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols |
CA2306772C (en) * | 1996-12-17 | 2004-10-12 | Laura Pope | Use of c18 to c26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
US6019997A (en) * | 1997-01-09 | 2000-02-01 | Minnesota Mining And Manufacturing | Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents |
US5871763A (en) * | 1997-04-24 | 1999-02-16 | Fort James Corporation | Substrate treated with lotion |
-
2002
- 2002-10-15 CN CNA028251695A patent/CN1633306A/zh active Pending
- 2002-10-15 HU HU0402624A patent/HUP0402624A3/hu unknown
- 2002-10-15 CA CA002421026A patent/CA2421026C/en not_active Expired - Fee Related
- 2002-10-15 NZ NZ532944A patent/NZ532944A/en not_active IP Right Cessation
- 2002-10-15 YU YU31104A patent/YU31104A/sh unknown
- 2002-10-15 BR BR0213323-7A patent/BR0213323A/pt not_active IP Right Cessation
- 2002-10-15 JP JP2003535721A patent/JP2005519868A/ja active Pending
- 2002-10-15 EA EA200400535A patent/EA200400535A1/ru unknown
- 2002-10-15 EP EP02795523A patent/EP1436006A4/en not_active Withdrawn
- 2002-10-15 WO PCT/US2002/033019 patent/WO2003032915A2/en active IP Right Grant
- 2002-10-15 PL PL02371945A patent/PL371945A1/xx unknown
- 2002-10-15 US US10/312,321 patent/US20040033982A1/en not_active Abandoned
- 2002-10-15 RU RU2004115001/15A patent/RU2004115001A/ru not_active Application Discontinuation
- 2002-10-16 AR ARP020103878A patent/AR036834A1/es not_active Application Discontinuation
-
2004
- 2004-04-07 IS IS7212A patent/IS7212A/is unknown
- 2004-04-16 MX MXJL04000011A patent/MXJL04000011A/es unknown
- 2004-05-11 HR HRP20040421AA patent/HRP20040421B1/hr not_active IP Right Cessation
- 2004-05-14 ZA ZA200403707A patent/ZA200403707B/en unknown
- 2004-05-14 NO NO20041999A patent/NO20041999L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HRP20040421B1 (hr) | 2013-05-31 |
NZ532944A (en) | 2005-10-28 |
RU2004115001A (ru) | 2005-04-10 |
HRP20040421A2 (en) | 2004-08-31 |
EA200400535A1 (ru) | 2005-06-30 |
BR0213323A (pt) | 2005-01-25 |
EP1436006A2 (en) | 2004-07-14 |
CN1633306A (zh) | 2005-06-29 |
IS7212A (is) | 2004-04-07 |
NO20041999L (no) | 2004-05-14 |
PL371945A1 (en) | 2005-07-11 |
ZA200403707B (en) | 2004-12-14 |
CA2421026C (en) | 2005-02-15 |
US20040033982A1 (en) | 2004-02-19 |
EP1436006A4 (en) | 2006-06-07 |
MXJL04000011A (es) | 2004-07-08 |
JP2005519868A (ja) | 2005-07-07 |
WO2003032915A2 (en) | 2003-04-24 |
CA2421026A1 (en) | 2003-04-16 |
HUP0402624A2 (hu) | 2005-07-28 |
WO2003032915A3 (en) | 2004-02-26 |
HUP0402624A3 (en) | 2008-04-28 |
AR036834A1 (es) | 2004-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2014005I2 (el) | Τοπικα συστηματα παροχης γελης για την θεραπευτικη αντιμετωπιση των διαταραχων δερματος | |
MXPA04001034A (es) | Compuestos para sanar heridas y en contra de envejecimiento. | |
CY1108633T1 (el) | Κοσμητικη συνθεση βασεως σουκραλφατ και θειικων αλατων χαλκου και ψευδαργυρου | |
AUPQ877300A0 (en) | Topical treatment of skin | |
IL166016A0 (en) | Topical treatment of skin diseases | |
YU31104A (sh) | Inhibicija virusa n-dokozanolom | |
MY134288A (en) | Composition and its therapeutic use | |
DE60119976D1 (en) | Thixotropes nasenspray | |
GB0312566D0 (en) | Veterinary composition for the topical treatment of traumatized or inflamed skin | |
DK1049461T3 (da) | Anvendelse af topiske præparater af glyceryltrinitrat og lanolin til behandling af erektil dysfunktion | |
AU2001284743A1 (en) | Therapeutic topical solution for skin and associated methods of use | |
AU2001291604A1 (en) | Use of proton pump inhibitors for treating diseases of the locomotor system | |
AU2002325261A1 (en) | Preparation used for the topical treatment of pains and skin diseases | |
IL119990A0 (en) | Topical compositions for the treatment of skin diseases | |
AU2908501A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
AU2002224905A1 (en) | Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes | |
AU2728301A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
AU2001272195A1 (en) | Topical treatment of skin | |
ATE278410T1 (de) | Ätherische öle zur topischen therapie von herpes labialis | |
GB0028468D0 (en) | Composition for topical treatment of skin | |
SE9900891D0 (sv) | Topical composition for dermatological and cosmetic treatment of the skin | |
UA40081A (uk) | Спосіб лікування гіперплазії лімфоїдної тканини носоглотки | |
IT1275623B1 (it) | Uso terapeutico e cosmetico degli allumi | |
LV12765A (lv) | Powder quicksand | |
IL153491A0 (en) | Dermatological and cosmetic composition for topical treatment of herpes infections |